Terms: = Lung cancer AND RALGDS, FLJ20922, 5900, ENSG00000160271, RalGEF, RGF, Q12967
22 results:
1. Racial and Ethnic Disparities in lung cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study.
Aredo JV; Choi E; Ding VY; Tammemägi MC; Ten Haaf K; Luo SJ; Freedman ND; Wilkens LR; Le Marchand L; Wakelee HA; Meza R; Park SL; Cheng I; Han SS
JNCI Cancer Spectr; 2022 May; 6(3):. PubMed ID: 35642317
[TBL] [Abstract] [Full Text] [Related]
2. Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non-small cell lung cancer.
Zhao Q; Li B; Xu Y; Wang S; Zou B; Yu J; Wang L
Cancer Med; 2021 Sep; 10(18):6291-6303. PubMed ID: 34390218
[TBL] [Abstract] [Full Text] [Related]
3. Low expression of RGL4 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients.
Sun Y; Zhang Y; Ren S; Li X; Yang P; Zhu J; Lin L; Wang Z; Jia Y
Int Immunopharmacol; 2020 Jun; 83():106454. PubMed ID: 32259700
[TBL] [Abstract] [Full Text] [Related]
4. Perioperative lung Resection Outcomes After Implementation of a Multidisciplinary, Evidence-based Thoracic ERAS Program.
Haro GJ; Sheu B; Marcus SG; Sarin A; Campbell L; Jablons DM; Kratz JR
Ann Surg; 2021 Dec; 274(6):e1008-e1013. PubMed ID: 31851005
[TBL] [Abstract] [Full Text] [Related]
5. A pan-cancer study of copy number gain and up-regulation in human oncogenes.
Wee Y; Wang T; Liu Y; Li X; Zhao M
Life Sci; 2018 Oct; 211():206-214. PubMed ID: 30243646
[TBL] [Abstract] [Full Text] [Related]
6. RASSF1A Deficiency Enhances RAS-Driven lung Tumorigenesis.
Schmidt ML; Hobbing KR; Donninger H; Clark GJ
Cancer Res; 2018 May; 78(10):2614-2623. PubMed ID: 29735543
[TBL] [Abstract] [Full Text] [Related]
7. Metformin Enhances the Effect of Regorafenib and Inhibits Recurrence and Metastasis of Hepatic Carcinoma After Liver Resection via Regulating Expression of Hypoxia Inducible Factors 2α (HIF-2α) and 30 kDa HIV Tat-Interacting Protein (TIP30).
Yang Q; Guo X; Yang L
Med Sci Monit; 2018 Apr; 24():2225-2234. PubMed ID: 29654226
[TBL] [Abstract] [Full Text] [Related]
8. Coexistence of sensitive and resistant epidermal growth factor receptor (EGFR) mutations in pretreatment non-small cell lung cancer (NSCLC) patients: First or third generation tyrosine kinase inhibitors (TKIs)?
Zhang B; Xu J; Zhang X; Gu P; Wang H; Wang S; Qian J; Qiao R; Zhang Y; Yang W; Qian F; Zhou Y; Lu J; Zhang L; Han B
Lung Cancer; 2018 Mar; 117():27-31. PubMed ID: 29496252
[TBL] [Abstract] [Full Text] [Related]
9. Differential Effector Engagement by Oncogenic KRAS.
Yuan TL; Amzallag A; Bagni R; Yi M; Afghani S; Burgan W; Fer N; Strathern LA; Powell K; Smith B; Waters AM; Drubin D; Thomson T; Liao R; Greninger P; Stein GT; Murchie E; Cortez E; Egan RK; Procter L; Bess M; Cheng KT; Lee CS; Lee LC; Fellmann C; Stephens R; Luo J; Lowe SW; Benes CH; McCormick F
Cell Rep; 2018 Feb; 22(7):1889-1902. PubMed ID: 29444439
[TBL] [Abstract] [Full Text] [Related]
10. RalGPS2 Is Essential for Survival and Cell Cycle Progression of lung cancer Cells Independently of Its Established Substrates Ral GTPases.
O Santos A; Parrini MC; Camonis J
PLoS One; 2016; 11(5):e0154840. PubMed ID: 27149377
[TBL] [Abstract] [Full Text] [Related]
11. Cause-specific premature death from ambient PM2.5 exposure in India: Estimate adjusted for baseline mortality.
Chowdhury S; Dey S
Environ Int; 2016 May; 91():283-90. PubMed ID: 27063285
[TBL] [Abstract] [Full Text] [Related]
12. Principles of K-Ras effector organization and the role of oncogenic K-Ras in cancer initiation through G1 cell cycle deregulation.
Nussinov R; Tsai CJ; Muratcioglu S; Jang H; Gursoy A; Keskin O
Expert Rev Proteomics; 2015; 12(6):669-82. PubMed ID: 26496174
[TBL] [Abstract] [Full Text] [Related]
13. Ras effector mutant expression suggest a negative regulator inhibits lung tumor formation.
Vandal G; Geiling B; Dankort D
PLoS One; 2014; 9(1):e84745. PubMed ID: 24489653
[TBL] [Abstract] [Full Text] [Related]
14. Pin1 promoter rs2233678 and rs2233679 polymorphisms in cancer: a meta-analysis.
Zhu YM; Liu JW; Xu Q; Yuan Y
Asian Pac J Cancer Prev; 2013; 14(10):5965-72. PubMed ID: 24289610
[TBL] [Abstract] [Full Text] [Related]
15. RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancer.
Guerrero-Setas D; Pérez-Janices N; Blanco-Fernandez L; Ojer A; Cambra K; Berdasco M; Esteller M; Maria-Ruiz S; Torrea N; Guarch R
Mod Pathol; 2013 Aug; 26(8):1111-22. PubMed ID: 23542458
[TBL] [Abstract] [Full Text] [Related]
16. Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC.
Samakoglu S; Deevi DS; Li H; Wang S; Murphy M; Bao C; Bassi R; Prewett M; Tonra JR
Cancer Genomics Proteomics; 2012; 9(2):77-92. PubMed ID: 22399498
[TBL] [Abstract] [Full Text] [Related]
17. Choline kinase: an important target for cancer.
Janardhan S; Srivani P; Sastry GN
Curr Med Chem; 2006; 13(10):1169-86. PubMed ID: 16719778
[TBL] [Abstract] [Full Text] [Related]
18. AIRFIX: the first digital postoperative chest tube airflowmetry--a novel method to quantify air leakage after lung resection.
Anegg U; Lindenmann J; Matzi V; Mujkic D; Maier A; Fritz L; Smolle-Jüttner FM
Eur J Cardiothorac Surg; 2006 Jun; 29(6):867-72. PubMed ID: 16675248
[TBL] [Abstract] [Full Text] [Related]
19. RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1.
Tommasi S; Dammann R; Jin SG; Zhang XF; Avruch J; Pfeifer GP
Oncogene; 2002 Apr; 21(17):2713-20. PubMed ID: 11965544
[TBL] [Abstract] [Full Text] [Related]
20. Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience.
Lee CK; Aeppli DM; Unger J; Boudreau RJ; Levitt SH
Am J Clin Oncol; 1996 Apr; 19(2):102-7. PubMed ID: 8610630
[TBL] [Abstract] [Full Text] [Related]
[Next]
